stockrowAlign Technology, Inc.
ALGN Healthcare Medical Instruments & Supplies
Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024.
- Revenue
- +1.92%
- EPS
- +143.9%
- Free cash flow
- +8.26%
Quarter to September 2026, against a year earlier
Follow ALGN
Alert me
Align Technology, Inc. 10-Q filed Nov 4, 2026
What changed
Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Aug 5, 2026: 9 added · 3 removed · 27 modified; 43 with only figures updated; 4 moved without change
-
Modified · Recent Developments
UK VAT Update: On July 7, 2026, the Upper Tribunal (Tax and Chancery Chamber) of the United Kingdom issued a decision reversing the April 24, 2025 decision of the First-tier Tribunal and holding that clear aligners are not “dental prostheses” and are therefore subject to value added tax in the United Kingdom at the standard rate. We have recorded an estimated liability of approximately $
37.543.1 million as ofJuneSeptember 30, 2026, which reflects management’s best estimate of the obligation as of the reporting date. We intend to exhaust all available appeals and vigorously defend our position, but the ultimate resolution of this matter remains subject to significant uncertainty. Effective September 7, 2026, invoices due to UK customers for clear aligners and retainers include VAT at the applicable rate. For more information, see Note78 “Commitments and Contingencies” of the Notes to Condensed Consolidated Financial Statements.